「ag」の検索結果
41件：31～35件目を表示
-
お知らせ | 千寿製薬株式会社
a BAC-free formulation of Aibeta® combination eye drops（PDF） 2025年03月07日 Announcement of Licensing Agreement with Brill International（PDF） 2025年02月20日 Launch and Distribution of “MIEr for BeelineMED”...
http://www.senju.co.jp/chinese/news/ -
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
quarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: To...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
d by ocular surface disorder” *. Recently, the number of DED patients has been increasing due to an aging population, the long-term use of contact lenses, and the widespread use of Visual Display Term...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
quarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: To...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf